rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1993-7-28
|
pubmed:abstractText |
Of 4,000 endocervical specimens tested with the Chlamydiazyme enzyme-linked immunosorbent assay (Abbott Laboratories), 233 (5.8%) gave positive results (A492 above the cutoff), which were confirmed with a blocking reagent (Abbott). An additional 34 specimens (14.6%) with chlamydial antigen were detected and confirmed with the direct fluorescent-antibody test (Syva) from among those 66 Chlamydiazyme-negative specimens which had A492s that ranged from 0.030 to the cutoff and that could be blocked by > or = 50% with the blocking reagent.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0095-1137
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1646-7
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8315010-Antigens, Bacterial,
pubmed-meshheading:8315010-Cervix Uteri,
pubmed-meshheading:8315010-Chlamydia Infections,
pubmed-meshheading:8315010-Chlamydia trachomatis,
pubmed-meshheading:8315010-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8315010-Evaluation Studies as Topic,
pubmed-meshheading:8315010-Female,
pubmed-meshheading:8315010-Fluorescent Antibody Technique,
pubmed-meshheading:8315010-Humans,
pubmed-meshheading:8315010-Pregnancy,
pubmed-meshheading:8315010-Sensitivity and Specificity
|
pubmed:year |
1993
|
pubmed:articleTitle |
Direct fluorescent-antibody confirmation of chlamydial antigen below the detection threshold of the chlamydiazyme enzyme-linked immunosorbent assay.
|
pubmed:affiliation |
Immunology Laboratory, York Hospital, Pennsylvania 17405.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|